Global Auto-Immune Diseases Pipeline Research Report 2023: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape

News provided by

Jan 16, 2024, 12:45 ET

DUBLIN, Jan. 16, 2024 /PRNewswire/ -- The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Auto-Immune Diseases Pipeline Report provides comprehensive information about the Auto-Immune Diseases pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Auto-Immune Diseases Diagnostic Tests are used for detection of autoimmune disorder by identifying auto-antibodies in the patient's test sample.

This report offers extensive coverage of Auto-Immune Diseases under development, providing comprehensive insights into pipeline products, major players, developmental activities, clinical trial data, and recent developments in the segment/industry. The report reviews the details of major pipeline products, including product descriptions, licensing and collaboration details, and other developmental activities related to Auto-Immune Diseases. It also lists all the pipeline projects involving major players engaged in the development of Auto-Immune Diseases.

Coverage of pipeline products is based on various stages of development, ranging from Early Development to Approved/Issued stages, allowing readers to understand the progress of these products in the pipeline. Key clinical trial data related to ongoing trials specific to pipeline products in the Auto-Immune Diseases segment is provided, offering valuable insights into the clinical development of these products.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Auto-Immune Diseases under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Auto-Immune Diseases Overview

3 Products under Development
3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development
3.2 Auto-Immune Diseases - Pipeline Products by Territory
3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path
3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
3.5 Auto-Immune Diseases - Ongoing Clinical Trials

4 Auto-Immune Diseases - Pipeline Products under Development by Companies
4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development

5 Auto-Immune Diseases Companies and Product Overview

6 Auto-Immune Diseases- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

Aarhus University
Adaptive Biotechnologies Corp
Aditxt Inc
Albert Ludwigs University of Freiburg
Alere Inc
Amarantus Diagnostics Inc
apDia nv
Asylia Diagnostics BV
Autoimmune Technologies LLC
Avotres Inc
Beckman Coulter Inc
Bellvitge Biomedical Research Institute
BG Medicine Inc
Biogen Inc
BIOHOPE Scientific SL
Biomedal SL
Bionure Farma SL (Inactive)
BioShai Ltd
Biotome Pty Ltd
CDI Laboratories Inc
Celdara Medical LLC
Charite University Hospital of Berlin
Chronix Biomedical Inc
Cincinnati Children's Hospital Medical Center
Cizzle Biotechnology Holdings Plc
Co-Diagnostics Inc
Columbia University
Crescendo Bioscience Inc
Department of Biomedical Engineering Columbia University
Digna Biotech SL
DNAlytics SA
Enterome Bioscience SA
Exagen Diagnostics Inc
Exodus Biosciences LLC
Ezose Sciences Inc.
Flamentera AG
Genalyte Inc
GeNeuro SA
Grifols SA
Guangzhou Wondfo Biotech Co Ltd
Hannover Medical School
HealthTell Inc
Helmholtz Centre for Infection Research
HOB Biotech Group Suzhou Co Ltd
Hospital for Special Surgery
HTG Molecular Diagnostics Inc
Hycor Biomedical Inc
Ignyta Inc
Immunarray Pvt Ltd
Immunovia AB
ImmusanT Inc
Innobiochips
Inova Diagnostics Inc
InterVenn BioSciences
Iron Horse Diagnostics, Inc.
Johns Hopkins University
Lankenau Institute for Medical Research
LineaGen Inc
Lophius Biosciences GmbH
Louisville Bioscience Inc (Inactive)
Max Delbruck Center for Molecular Medicine
Mayo Clinic
Medica Corp
Medical & Biological Laboratories Co Ltd
Metabiomics Corporation
Metabolomic Technologies Inc
Metanomics Health GmbH
MSDx Inc
Myriad Genetics Inc
Nanosphere Inc (Inactive)
Neuro Vigor LLC
NoToPharm srl
Numares AG
OmniBiome Therapeutics Inc
One Way Liver SL
OPKO Health Inc
Op-T-Mune Inc
Oxford Biodynamics Plc
Oxford Gene Technology Ltd
Oxford Immunotec Ltd
Pediatric Bioscience LLC
Penn State College of Medicine
Progentec Diagnostics Inc
Prometheus Biosciences Inc
Protagen AG
ProteinLogic Ltd
Psyros Diagnostics Ltd
Quanterix Corp
Rambam Health Care Campus
Rappaport Family Institute for Research in the Medical Science
Revvity Inc
Roche Diagnostics
Roche Diagnostics International Ltd
Royal College of Surgeons Ireland
Seattle Children's Hospital
Sengenics Corp Pte Ltd
Sequenom Inc
Shuwen Biotech Co Ltd
SomaLogic Inc
Southern Illinois University Carbondale
Spanish National Research Council
SQI Diagnostics Inc
Statens Serum Institut
Sugentech Inc
Svar Life Science AB
TBG Diagnostics Ltd
Tel Aviv University
The Walter and Eliza Hall Institute of Medical Research
Toscana Biomarkers Srl
University Health Network
University of Alberta
University of California Irvine
University of California San Francisco
University of Chicago
University of Colorado
University of Illinois at Chicago
University of Maryland Baltimore
University of Missouri
University of Oslo
University of Oxford
University of Pecs
US Biomarkers Inc
Veravas Inc
VolitionRX Ltd
Washington University in St Louis
XEPTAGEN SpA
Yale University

For more information about this report visit https://www.researchandmarkets.com/r/jck800

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets